已收盘 02-13 16:00:00 美东时间
-0.225
-0.87%
PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patients With Myeloproliferative Neoplasms NSP: -32% | Insperity shares are trading
2025-11-04 20:24
Insperity (NYSE:NSP) is looking for Q4 Adj EPS of $(0.79)-$(0.16) vs $0.08 analyst estimate..
2025-11-04 05:59
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
原标题:现象级大药机会,被引爆 我们不止一次提到过呼吸疾病赛道的巨大机会,包括《一个超级大药机会,将被引爆》、《下一个现象级大药蓄势》、《一哥超预期,引爆重磅...
2025-08-14 07:54
InspireMD appoints Michael Lawless as CFO, replacing Craig Shore after nearly 15 years, to lead the company's growth phase, including the U.S. launch of CGuard Prime. Lawless brings extensive healthcare financial leadership experience. As part of the inducement compensation, he will receive restricted stock and stock options vesting over three years.
2025-06-03 20:05
U.S. stocks were lower, with the Nasdaq Composite falling around 650 points on ...
2025-03-11 00:15
William Blair analyst Andrew Nicholas downgrades Insperity (NYSE:NSP) from Outperform to Market Perform.
2024-09-24 21:32
05:17 PM EDT, 08/27/2024 (MT Newswires) -- Insperity (NSP) said late Tuesday that it has appointed James Allison as chief financial officer, succeeding Douglas Sharp, who will retire. Both changes are effective Nov. 15, the company said. Allison currently serves as executive vice president of compre...
2024-08-28 05:17
Insperity, Inc. (NYSE:NSP), a leading provider of human resources and business performance solutions for America's best businesses, today announced that its executive vice president of finance, chief financial officer and treasurer, Douglas S. Sharp, has elected to retire on November 15, 2024, after...
2024-08-28 04:17